Investor Ideas #Potcasts #Cannabis News and Stocks on
the Move: Aurora Cannabis (TSX: $ACB.TO) (NYSE: $ACB), Khiron Life Sciences
(TSXV: $KHRN.V), (OTCQB: $KHRNF), Cannabis One Holdings (CSE: $CBIS.C), Liht
Cannabis (CSE: $LIHT.C) and FSD Pharma (CSE: $HUGE.C) (OTCQB: $FSDDF)
Delta,
Kelowna, BC –March 13, 2019 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release today’s edition
of Investorideas.com potcastsCM - cannabis
news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/03131ACB-KHRN-KHRNF-CBIS-LIHT-HUGE-FSDDF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another Investorideas.com “potcast”, looking at
cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today
we are looking at announcements from Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB), Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF), Cannabis One Holdings Inc. (CSE:CBIS), Liht Cannabis Corp. (CSE:LIHT) and FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF).
Khiron
Life Sciences Corp., a vertically integrated cannabis leader with core
operations in Latin America, announced today the appointment of Dr. Edwin Bendek MD,
MA, MPH as Medical Director, Skincare. This appointment expands the Company's
scientific expertise and resources for future product and brand development,
global strategic alliances and research and education initiatives across Latin
America.
Andres
Galofre, Khiron Co-founder and VP Business Development, stated, " The
appointment of Dr. Bendek is an important addition to our skincare unit as we
ramp up retail distribution, and further advance new product research and
development. Dr. Bendek's proven skincare and cosmetology experience, together
with his exceptional industry network will be invaluable as we execute our
research-based, product development strategy."
Dr.
Bendek, brings 20 years of global experience in general dermatology, cutaneous
surgery, anti-aging dermatology and predictive genetics. A graduate of Medical
Dermatology from Universidad Javeriana, Colombia, specialist in anti-aging from
the WOSIAM in Paris, Master in Public Health from the Universidad de Granada,
Master in Bioethics, Health and Law from the Université de Rennes and
Specialist in clinical trials from Harvard University, Dr. Bendek is a regular
speaker at national and international events, and is considered a pioneer in
CBD cosmeceutical product development.
Aurora
Cannabis Inc., trading upwards of 10% following today’s announcement that it has appointed Nelson Peltz as a
Strategic Advisor. Mr. Peltz and Aurora will work collaboratively and
strategically to explore potential partnerships that would be the optimal
strategic fit for successful entry into each of Aurora's contemplated market
segments. Mr. Peltz will also advise on the Company's global expansion
strategy.
"Nelson
is a globally recognized business visionary with a strong track record of
constructive engagement to generate accelerated, profitable growth and
shareholder value across many industry verticals that are of great interest to
us," said Terry Booth, CEO. "Like us, Nelson also takes a long-term
view of value creation to benefit all stakeholders. We look forward to working
with Nelson to further extend our global cannabis industry leadership by
aligning Aurora with each of the major market segments cannabis is set to
impact."
Mr.
Peltz, added, "I believe Aurora has a solid execution track record, is
strongly differentiated from its peers, has achieved integration throughout the
value chain and is poised to go to the next level across a range of industry
verticals. I also believe that Canadian licensed producers, and Aurora in
particular, are well positioned to lead in the development of the international
cannabis industry as regulations evolve, with a strong, globally replicable
operating model. I look forward to working with Terry and the extended Aurora
team to evaluate its many operational and strategic opportunities, including
potential engagement with mature players in consumer and other market
segments."
Cannabis
One Holdings Inc., an emerging, premier "House of Brands" in North
America, announced that effective March 5, 2019, it has
executed a letter of intent to acquire majority ownership in California license
holder, "420 Express Delivery Inc.", which operates, "Green Leaf
Wellness", a dispensary located in the Coachella Valley of California,
from Liht Cannabis Corp., a publicly-listed entity trading on the Canadian
Securities Exchange. Following the closing of the transaction, it is the
intention of the Company and Liht Cannabis to rebrand the operating entity,
"Green Leaf Wellness", under the banner of the Company's retail
concept The JointTM. The Company anticipates that this acquisition
will provide Cannabis One, along with its unique branded products and retail
presence, a foothold in the California market from which it may launch its
proposed expansion, with a management-projected target of four (4) additional
The JointTM locations in the state and a further twenty (20) The
JointTM locations planned to arrive in state-legal jurisdictions
across the U.S. in 2019, to complement this first transaction.
Following
the execution of the LOI, Cannabis One CEO, Jeffery Mascio commented, "The
Cannabis One team is pleased by this exciting opportunity to enter the
California market and we believe this acquisition positions our company
exceptionally well to promote the expansion of our portfolio of brands within
one of the world's most vibrant markets." Mr. Mascio continued,
"While we are naturally excited to introduce California to our The JointTM
retail experience -- named among LeaflyTM's top Colorado picks
for several years running -- and to roll-out our INDVRTM line of
vaporizer products across the state, we also view this acquisition as a significant
milestone for Cannabis One that now allows us to advance our partnerships
within the California cannabis manufacturing and distribution space for
exciting new strategic relationships."
FSD
Pharma Inc., a licensed producer under the Cannabis Act, today announced that Sara May, Ph.D., has been appointed
President of FV Pharma ("FV"), a wholly owned subsidiary of FSD
Pharma, effective immediately. Dr. May replaces Thomas Fairfull, former
President of FV Pharma, as Mr. Fairfull transitions out of the company.
Currently
responsible for quality assurance at FV Pharma, Dr. May has over ten years of
experience designing, implementing and managing large-scale research projects
in the field, laboratory and greenhouse settings. Additionally, Dr. May has
held numerous leadership positions within the medical cannabis industry where
she oversaw project operations and implementation of quality control and
quality assurance measures and standard operating procedures. Dr. May has
accumulated expertise in National, International, Provincial and Regional
Legislative Acts and Regulations.
"We
are excited to elevate Dr. May's current position to President of FV Pharma.
Her significant experience managing cannabis operations has already proven a
great addition to the company," said FSD Pharma Executive Co-Chairman and
CEO Dr. Raza Bokhari. "Her robust expertise has been remarkable and will
support efficient advancement of the strategic objectives of FV and FSD
Pharma."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the
Investorideas.com website
and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an
Investor ideas member , plus get weekly updates with new pot stocks added and
get the daily potcast for Investor Ideas #Potcasts
#Cannabis News and Stocks on the Move.
Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news and press releases plus
we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts ,
articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto
Corner and Podcast, Play by Play sports and stock
news column, Investor
Ideas #Potcasts #Cannabis News and Stocks
on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI Eye Podcast
and column covering developments in AI.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers.
Learn more about
Investor ideas podcast and news publication
services and costs https://www.investorideas.com/News-Upload/
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does
not condone the use of cannabis except where permissible by law. Our site does
not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment